• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

U.S. FDA

2026 year ahead look ahead preview forecast new year
Pharma

3 biopharma CEOs explain why they are 'authentically optimistic'

That was the consensus among leaders from three biopharma companies—Perspective, Lineage and Catalyst—who sat down with Fierce late last year.
Fraiser Kansteiner Jan 6, 2026 11:54am
Monjuvi

Incyte to seek FDA approval for Monjuvi in front-line DLBCL

Jan 5, 2026 10:40am
game over pivot new direction

InflaRx may find path forward for COVID drug in skin disorder

Jan 2, 2026 10:25am
Novo Nordisk

Novo snags FDA nod for oral obesity med with Wegovy in a pill

Dec 22, 2025 6:59pm
drugs 2025 2025 in pharma regulatory tracker pharma 2025

Regulatory tracker: Rubraca scores full prostate cancer approval

Dec 18, 2025 2:45pm
GSK London

GSK scoops up yet another FDA approval, this time in asthma

Dec 17, 2025 8:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings